___________________________________________________________________________________________________________________________________

Cancer Cell

Herrero, A. et al. Small molecule inhibition of ERK dimerization prevents tumorigenesis by RAS-ERK pathway oncogenes.
Cancer Cell 28, 170–182 (2015)

______________________________________________________________________________________________________________________________________

American Journal of Ophthalmology

Secondary Enucleations for Uveal Melanoma: A 7-Year Retrospective Analysis

Ido D. Fabian, MD, Oren Tomkins-Netzer, MD, Ian Stoker, Amit K. Arora, MD, Mandeep S. Sagoo, MD, Victoria M.L. Cohen, MD

Received: June 28, 2015; Received in revised form: August 20, 2015; Accepted: August 20, 2015; Published Online: September 03, 2015

Publication stage: In Press Accepted Manuscript

DOI: http://dx.doi.org/10.1016/j.ajo.2015.08.034

___________________________________________________________________________________________________________________________________________________

The Journal of Biological Chemistry

PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma^*

1. Jennifer D. Kubic^‡,
2. Jason W. Lui^‡1,
3. Elizabeth C. Little^‡1,
4. Anton E. Ludvik^‡,
5. Sasank Konda^‡,
6. Ravi Salgia,
7. Andrew E. Aplin^¶and
8. Deborah Lang^‡2

First Published on July 23, 2015, doi:10.1074/jbc.M115.670976

September 4, 2015The Journal of Biological Chemistry, 290, 21901-21914.

__________________________________________________________________________________________________________________________________________________

Journal of Biological Chemistry

Post-translational Down-regulation of Melanoma antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor

1. John T. Minges,Gail Grossman, Ping Zhang, Tal Kafri andElizabeth
2. Wilson

*

First Published onSeptember 1, 2015, doi:10.1074/jbc.M115.663641jbc.M115.663641.

________________________________________________________________________________________________________________

PNAS

Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination

1. Zachary Sanborn^a,¹,
2. Jongsuk Chung^b,¹,
3. Elizabeth Purdom^c
4. Nicholas J. Wang^d,
5. Hojabr Kakavand^e,
6. James S. Wilmott^e,
7. Timothy Butler^f,
8. John F. Thompson^e,^g,
9. Graham J. Mann^e,
10. Lauren E. Haydu^e,
11. Robyn P. M. Saw^e,^g,
12. Klaus J. Busam^h,
13. Roger S. Loⁱ,
14. Eric A. Collisson^j,
15. Joe S. Hur^k,
16. Paul T. Spellman^f,
17. James E. Cleaver^l,³,
18. Joe W. Gray^d,
19. Nam Huh^b,
20. Rajmohan Murali^m,
21. Richard A. Scolyer^e,^g,
22. Boris C. Bastianⁿ,²,³, and
23. Raymond J. Cho^l,²,³

• doi: 10.1073/pnas.1508074112

___________________________________________________________________________________________________________________________________

Science Signaling

The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma

Sci. Signal.  18 Aug 2015:
Vol. 8, Issue 390, pp. ra82
DOI: 10.1126/scisignal.aab1111

__________________________________________________________________________________________________

Oncogene

Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling
OPEN

F Kruiswijk^1,8, S C Hasenfuss^1,8, R Sivapatham^2,8, M P Baar³, D Putavet³, K A T Naipal³, N J F van den Broek¹, W Kruit⁴, P J van der Spek⁵, D C van Gent³, A B Brenkman^1,6, J Campisi^2,7, B M T Burgering¹, J H J Hoeijmakers³ and P L J de Keizer^1,2,3

Oncogene advance online publication 17 August 2015; doi: 10.1038/onc.2015.282

__________________________________________________________________________________________________

Nanomedicine

In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells

Anupma Dwivedi, PhD

,

 Anisha Mazumder

, PhDLissinda du Plessis, PhDJan L. du Preez, PhDRichard K. Haynes, PhDJeanetta du Plessis, PhD

Received: May 7, 2015; Received in revised form: July 16, 2015; Accepted: July 17, 2015; Published Online: August 14, 2015

Publication stage: In Press Accepted Manuscript

DOI: http://dx.doi.org/10.1016/j.nano.2015.07.010

______________________________________________________________________________________________________

Journal of Biological Chemistry

Fibroblast-Derived Neuregulin-1 Promotes Compensatory ErbB3 Signaling in Mutant BRAF Melanoma

1. Claudia Capparelli1,
2. Sheera Rosenbaum1,
3. Adam C. Berger2and
4. Andrew E. Aplin1*

August 12, 2015, doi:10.1074/jbc.M115.657270jbc.M115.657270.

____________

Weighing Treatment Decisions in Melanoma

Fuerst, Mark L.

Oncology Times:

25 August 2015 – Volume 37 – Issue 16 – p 16–17

doi: 10.1097/01.COT.0000471129.44460.7c

___________________________________________________________________________________________________

• Patient-centred medicine

Total skin self-examination at home for people treated for cutaneous melanoma: development and pilot of a digital intervention

1. Peter Murchie¹,
2. Julia L Allan²,
3. William Brant³,
4. Matthew Dennis⁴,
5. Susan Hall¹,
6. Judith Masthoff⁵,
7. Fiona M Walter⁶,
8. Marie Johnston²

BMJ Open 2015;5:e007993 doi:10.1136/bmjopen-2015-007993

______________________________________________________________________________________________________________

Review

Prognosis of uveal melanoma based on race in 8100 patients: The 2015 Doyne Lecture

C L Shields, S Kaliki, M N Cohen, P W Shields, M Furuta and J A Shields

Eye , (7 August 2015) | doi:10.1038/eye.2015.51

________________________________________________________________________________

Melanoma in the Italian Population and Regional Environmental Influences: A National Retrospective Survey on 2001–2008 Hospitalization Records

Prisco Piscitelli ^1,* , Cosimo

Neglia

 ²

, Andrea Falco ¹

, Matteo Rivezzi ¹

, Nadia Agnello ²

,Alberto Argentiero ²

, Giovanna Chitano ²

, Chiara Distante ²

, Giulia Della Rosa ²

, Giorgia Vinci ³

,Antonella De Donno ⁴

, Alessandro Distante ²

 and Antonella Romanini ⁵

Int. J. Environ. Res. Public Health 2015, 12(8), 9102-9118; doi:10.3390/ijerph120809102

European Journal of Pharmacology

Volume 764, 5 October 2015, Pages 372–378

Rethinking tamoxifen in the management of melanoma: New answers for an old question

• Mariana P.C. Ribeiro^a

^, b, , , 

• Armanda E. Santos^a

^, b, 

• José B.A. Custódio^a

^, b

_
Biochemical and Biophysical Research Communications

Volume 464, Issue 2, 21 August 2015, Pages 416–421

Tumor-suppressive effects of natural-type interferon-? through CXCL10 in melanoma

• Hikaru Kobayashi,
• Yoshimasa Nobeyama^,, 
• Hidemi Nakagawa

_____________________________________________________________________________

American Journal of Opthamology

Ocular toxicity in metastatic melanoma patients treated with Mitogen activated protein kinase inhibitors: a case series

Alfredo Niro, MD

,

 Sabino Strippoli

, MD

,

 Giovanni Alessio, MD

,

 Luigi Sborgia, MD,Nicola Recchimurzo, MD,Michele Guida, MD

Received: April 12, 2015; Received in revised form: July 22, 2015; Accepted: July 22, 2015; Published Online: July 28, 2015

Publication stage: In Press Accepted Manuscript

DOI: http://dx.doi.org/10.1016/j.ajo.2015.07.035